156 results on '"Amann, Arno"'
Search Results
2. PBRM1 mutations might render a subtype of biliary tract cancers sensitive to drugs targeting the DNA damage repair system
3. Stereotactic radiofrequency ablation of tumors at the hepatic venous confluence
4. Checkpoint inhibitors in metastatic gastric and GEJ cancer: a multi-institutional retrospective analysis of real-world data in a Western cohort
5. Deregulated glutamate to pro-collagen conversion is associated with adverse outcome in lung cancer and may be targeted by renin-angiotensin-aldosterone system (RAS) inhibition
6. Implementing liquid biopsies into clinical decision making for cancer immunotherapy.
7. Frequency and risk factors for major complications after stereotactic radiofrequency ablation of liver tumors in 1235 ablation sessions: a 15-year experience
8. Systematic review: Soluble immunological biomarkers in advanced non-small-cell lung cancer (NSCLC)
9. Molecular profile of BRCA-mutated biliary tract cancers
10. Established treatment concepts for recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSSC)
11. Whole stromal fibroblast signature is linked to specific chemokine and immune infiltration patterns and to improved survival in NSCLC
12. LM02 trial Perioperative treatment with panitumumab and FOLFIRI in patients with wild-type RAS, potentially resectable colorectal cancer liver metastases—a phase II study
13. Abstract 6668: Immune infiltrate co-occurrence and neoantigen similarity are prognostic factors in early stage NSCLC
14. Infiltration of lymphocyte subpopulations into cancer microtissues as a tool for the exploration of immunomodulatory agents and biomarkers
15. Incidental Diagnosis of Asymptomatic Non–Small-Cell Lung Cancer: A Registry-Based Analysis
16. Rectal cancer: latest developments and innovative new treatment concepts
17. Supplementary Figure from Comprehensive Analysis of R-Spondin Fusions and RNF43 Mutations Implicate Novel Therapeutic Options in Colorectal Cancer
18. Supplementary Table from Comprehensive Analysis of R-Spondin Fusions and RNF43 Mutations Implicate Novel Therapeutic Options in Colorectal Cancer
19. Characterization of DLK1(PREF1)+/CD34+ cells in vascular stroma of human white adipose tissue
20. Molecular Characteristics of Radon Associated Lung Cancer Highlights MET Alterations
21. Neoadjuvant chemo-immunotherapy modifies CD4+CD25+ regulatory T cells (Treg) in non-small cell lung cancer (NSCLC) patients
22. Evaluation of assays for drug efficacy in a three-dimensional model of the lung
23. Association of baseline soluble immune checkpoints with the risk of relapse in PR3-ANCA vasculitis following induction of remission
24. Molecular Characteristics of Radon Associated Lung Cancer Highlights MET Alterations
25. Bevacizumab: an option for refractory epistaxis in hereditary haemorrhagic telangiectasia
26. Predicting drug sensitivity by 3D cell culture models
27. Comprehensive Analysis of R-Spondin Fusions and RNF43 Mutations Implicate Novel Therapeutic Options in Colorectal Cancer
28. Association of baseline soluble immune checkpoints with the risk of relapse in PR3-ANCA vasculitis following induction of remission.
29. Stereotactic radiofrequency ablation of tumors at the hepatic venous confluence
30. sj-docx-1-tam-10.1177_17588359211039930 – Supplemental material for Benefit of second-line therapy for advanced esophageal squamous cell carcinoma: a tri-center propensity score analysis
31. Sorafenib in thyroid cancer—a retrospective case series
32. Identification and prognostic impact of PBRM1 mutations in biliary tract cancers: Results of a comprehensive molecular profiling study.
33. Stereotactic radiofrequency ablation (SRFA) for recurrent colorectal liver metastases after hepatic resection
34. High indoleamine-2,3-dioxygenase 1 (IDO) activity is linked to primary resistance to immunotherapy in non-small cell lung cancer (NSCLC)
35. Benefit of second-line therapy for advanced esophageal squamous cell carcinoma: a tri-center propensity score analysis
36. The role of maintenance therapy in metastatic colorectal cancer
37. Frequency and risk factors for major complications after stereotactic radiofrequency ablation of liver tumors in 1235 ablation sessions: a 15-year experience
38. LM02-trial perioperative treatment with panitumumab and FOLFIRI in patients with wild-type RAS, potentially resectable colorectal cancer liver metastases.
39. 3D-cultivation of NSCLC cell lines induce gene expression alterations of key cancer-associated pathways and mimicin-vivoconditions
40. Aviscumine, a recombinant ribosomal inhibitor, increases the antitumor activity of natural killer cells
41. Development of a 3D angiogenesis model to study tumour – endothelial cell interactions and the effects of anti-angiogenic drugs
42. The influence of stromal cells and tumor-microenvironment-derived cytokines and chemokines on CD3+CD8+ tumor infiltrating lymphocyte subpopulations
43. Treatment of patients with refractory metastatic cancer according to molecular profiling on tumor tissue in the clinical routine: an interim-analysis of the ONCO-T-PROFILE project
44. Reply
45. Abstract 4252: Establishment of a multicellular 3D cell culture model for tumor - endothelial cell interaction
46. The impact of metformin and salinomycin on transforming growth factor β-induced epithelial-to-mesenchymal transition in non-small cell lung cancer cell lines
47. Infiltration of immune cells into cancer cell/stroma cell 3D microtissues
48. Characterization of DLK1(PREF1) + /CD34 + cells in vascular stroma of human white adipose tissue
49. Abstract 326: Differences in RNA expression and chemosensitivity in 2D versus 3D non-small-cell lung cancer cultures
50. Abstract 316: Development of a novel 3D cancer model by cultivation of malignant effusions in a 3D cell culture system
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.